Stocks
Guardant Health (GH) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -54.9 | -225.1 | -359.6 | -614.9 | -433.3 | -466.9 | ||
| Changes by years, y/y, % | -34% | +310% | +60% | +71% | -30% | +39.2% | |||
Guardant Health. EBITDA US GAAP, bln rub
Guardant Health. EBITDA US GAAP, changes, %
Guardant Health. EBITDA US GAAP, sum by quarters, bln rub
Guardant Health (GH) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -73.9 | -176.1 | -103.2 | -91.2 | -96.5 | -466.9 | |
| Changes by years, y/y, % | -51% | +27% | -22% | +27% | +31% | |||
| Changes by quarters, q/q, % | +3% | +138% | -41% | -12% | +6% | |||
